Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data

2014 ◽  
Vol 24 (2) ◽  
pp. 242-252 ◽  
Author(s):  
S. Schrodi ◽  
A. Niedostatek ◽  
C. Werner ◽  
A. Tillack ◽  
G. Schubert-Fritschle ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Cancer Registry ◽  
Population Based ◽  
Registry Data ◽  
Breast Cancer Patients ◽  
Clinical Cancer Registry ◽  
Clinical Cancer ◽  
Cancer Registry Data ◽  
Primary Surgery

scholarly journals Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients

2013 ◽  
Vol 37 (5) ◽  
pp. 601-605 ◽  
Author(s):  
Anne Marie McCarthy ◽  
Erin McGuire ◽  
Mirar Bristol ◽  
Tracey Fredricks ◽  
Susan M. Domchek ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Cancer Registry ◽  
Hormone Receptor ◽  
Hormone Receptor Status ◽  
Registry Data ◽  
Breast Cancer Patients ◽  
Receptor Status ◽  
Cancer Registry Data ◽  
Young Breast Cancer

scholarly journals Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: A population-based study of Scottish cancer registry data

2019 ◽  
Author(s):  
Ines Mesa-Eguiagaray ◽  
Sarah H Wild ◽  
Philip S. Rosenberg ◽  
Sheila M Bird ◽  
David H Brewster ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Cancer Incidence ◽  
Molecular Subtypes ◽  
Breast Cancer Incidence ◽  
Temporal Trends ◽  
Population Based ◽  
Registry Data ◽  
Cancer Registry Data ◽  
Er Status

AbstractBackgroundStrategies for breast cancer prevention are informed by assessing whether incidence differs by tumour biology. We describe temporal trends of breast cancer incidence by molecular subtypes in Scotland.MethodsPopulation-based cancer registry data on 72,217 women diagnosed with incident primary breast cancer from 1997 to 2016 were analysed. Age-standardised rates (ASR) and age-specific incidence were estimated by tumour subtype after imputing the 8% of missing oestrogen receptor (ER) status. Joinpoint regression and age- period- cohort models were used to assess whether significant differences were observed in incidence trends by ER status.ResultsER positive tumour incidence steadily increased particularly for women of screening age 50 to 69 years from 1997 till around 2011 (1.6%/year, 95%CI: 1.2 to 2.1). ER negative incidence decreased among all ages at a consistent rate of −0.7%/year (95%CI: −1.5, 0) from around 2000-2016. Compared to the 1941-1959 central birth cohort, women born 1912-1940 had lower incidence rate ratios (IRR) for ER+ tumours and women born 1960- 1986 had higher IRR for ER- tumours.ConclusionsWe show evidence of aetiologic heterogeneity of breast cancer. Future incidence and survival reporting should be monitored by molecular subtypes.

scholarly journals Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data

CMAJ Open ◽  
2017 ◽  
Vol 5 (3) ◽  
pp. E734-E739 ◽  
Author(s):  
Saber Fallahpour ◽  
Tanya Navaneelan ◽  
Prithwish De ◽  
Alessia Borgo
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Cancer Survival ◽  
Molecular Subtype ◽  
Population Based ◽  
Breast Cancer Survival ◽  
Registry Data ◽  
Cancer Registry Data ◽  
Subtype A
Sign in / Sign up

Export Citation Format

Share Document